Editorial: Role of innate and adaptive immune cells in the metabolic syndrome

Payel Roy; Holger Winkels; Marco Orecchioni; Estefania Quesada-Masachs; Thomas Riffelmacher

doi:10.3389/fcell.2024.1383642

Editorial: Role of innate and adaptive immune cells in the metabolic syndrome

Front Cell Dev Biol. 2024 Feb 22:12:1383642. doi: 10.3389/fcell.2024.1383642. eCollection 2024.

Authors

Payel Roy^{1

2}, Holger Winkels^{3

4}, Marco Orecchioni^{1

2}, Estefania Quesada-Masachs¹, Thomas Riffelmacher^{1

5}

Affiliations

¹ Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, United States.
² Immunology Center of Georgia, Augusta University, Augusta, GA, United States.
³ University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine, Cologne, Germany.
⁴ Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
⁵ Immunometabolism Core Facility, La Jolla Institute for Immunology, La Jolla, CA, United States.

No abstract available

Keywords: chronic disease; immune cells; inflammation; metabolism; signaling; therapies.

Publication types

Editorial

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. HW is supported by Deutsche Forschungsgemeinschaft (GRK 2407: 360043781); SFB TRR259 (397484323 project A04 and A09 and project 535107899); the Center for Molecular Medicine Cologne; and the Neven-DuMont Foundation. MO is supported by American Heart Association’s Career Development Award (941152). EQ-M is supported by NIH R01AI092453.